About 30% of melanoma patients infused with T cells transduced with a high affinity receptor recognizing melanoma differentiation antigens Melan-A/MART1 or gp100 showed objective cancer regression, while 50% of the patients developed vitiligo and sometimes destruction of melanocytes in the eye and inner ear [108]. The gene discussed is MLANA; the disease is cancer.